inVentiv Health launches new European shop

Share this article:
49331_ncgsmc_gsw_wht_paper_16

Healthcare marketing agency inVentiv Health has further extended its breadth of services to the European market with the launch of a new shop called inVentiv Health Communications/Europe.

The new agency will be led by Bob Chandler, founder of Chandler Chicco Companies and SVP, marketing and communications at inVentiv Health. Headquartered in London, inVentiv Health Communications/Europe will now encompass previously established inVentiv Euro shops GSW Europe and Junction 11, in addition to the organization's new branch.

“The power of the well-regarded assets of inVentiv Health Communications/Europe, now working in greater unison, will have a profound impact on how we tackle opportunities emerging every day in the evolving European healthcare environment,” said Chandler in a statement. “Our new way of going to market is designed to facilitate a multidisciplinary approach to driving plans and programs that reach intended target audiences with greater speed and relevancy. We believe this efficiency will generate financial savings for our clients.”  

inVentiv Health has also released its Q2 financial information, reportedly earning $220.5 million in net revenue for the company's commercial business as of June 30 this year, a 14% increase since Q2 2010. Part of this sum is accounted for in inVentiv's acquisition of pharma and biotech consulting firm Campbell Alliance, which the company purchased this past February.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...